Introduction
============

BubR1 is a key component of the spindle assembly checkpoint (SAC), the surveillance mechanism which detects improper kinetochore--spindle linkages and delays anaphase onset until proper attachments are established ([@bib24]). BubR1, like Mad2, binds directly to and inhibits Cdc20, the essential cofactor required by the anaphase-promoting complex/cyclosome (APC/C) to initiate mitotic exit. In addition to their roles in the SAC, BubR1 and Mad2 also determine basal mitotic timing, which is the minimum time that elapses between nuclear envelope breakdown (NEB) and anaphase onset even when there are no unattached kinetochores (i.e., no SAC delay; [@bib23]). BubR1 also has a third function, promoting proper kinetochore--microtubule (MT \[K--MT\]) linkages ([@bib16]). This multifunctionality makes the phenotypes resulting from BubR1 inactivation difficult to interpret. For example, it is not known to what extent these different activities are interdependent. Is the SAC activity part of the activity-promoting K--MT linkages and vice versa? Is the timer function intrinsic to SAC function?

One way to address these questions is to identify specific mutations in BubR1 that affect one function but leave the others relatively intact. Such separation-of-function mutations would be invaluable for better understanding the contribution of BubR1 to mitosis and the SAC. The BubR1 protein has well-defined domains that might correlate with its presumed activities. The N-terminal half of metazoan BubR1 is similar to yeast MAD3, including a CDC20-binding region that encompasses two KEN boxes, both of which are critical for Mad3 binding to Cdc20 and consequently for SAC-mediated inhibition of the APC/C ([@bib28]).

Unlike Mad3, the C-terminal half of BubR1 in most metazoans encodes a kinase whose role in the SAC, and in mitosis generally, is controversial. It has been reported to be both essential and dispensable for the SAC, depending on the study ([@bib31]; [@bib5]; [@bib7]; [@bib22]). It is also unclear whether the kinase activity is critical to promoting proper K--MT linkages ([@bib9]; [@bib35]; [@bib11]; [@bib21]).

In *Drosophila melanogaster*, cells apparently do not need the SAC for accurate mitosis ([@bib4]), thus providing a clean baseline for assaying mitotic perturbations. Therefore, we examined in vivo mutations in fly BubR1 analogous to those described in the previous paragraphs in the kinase domain and the KEN box that would potentially separate its various activities.

Results and discussion
======================

Inefficient spindle assembly in *bubR1--kinase-dead* (*KD*) cells
-----------------------------------------------------------------

To determine what aspects of BubR1 function depend critically on the kinase, we generated a *bubR1-KD* allele (K1204A) and assayed its mitotic functions in vivo in larval neuroblasts ([Fig. 1 A](#fig1){ref-type="fig"}). *bubR1-KD* flies were viable and fertile, and only 1% of neuroblasts were aneuploid ([Table I](#tbl1){ref-type="table"}), which is far lower than the 25--50% seen in the genetic null *bubR1^1^* or other SAC mutations ([@bib2]; [@bib1]). Except for an increase in the prometaphase--metaphase/anaphase ratio in *bubR1-KD* cells (3.9 vs. 2.6 in wild type \[WT\]; unpublished data), mitosis appeared normal in fixed material.

###### 

Analysis of the mitotic parameters in *bubR1* mutant neuroblasts

  Strain[a](#tblfn1){ref-type="table-fn"}   Time in colchicine   Mitotic density[b](#tblfn2){ref-type="table-fn"}[c](#tblfn3){ref-type="table-fn"}   Relative mitotic density   Aneuploidy[c](#tblfn3){ref-type="table-fn"}   PSCS[c](#tblfn3){ref-type="table-fn"}   Notes
  ----------------------------------------- -------------------- ----------------------------------------------------------------------------------- -------------------------- --------------------------------------------- --------------------------------------- --------
                                            *min*                                                                                                                               *%*                                           *%*                                     
  WT (5)                                    0                    2.11 (0.26)                                                                         1                          0.2 (0.22)[d](#tblfn4){ref-type="table-fn"}   NA                                      viable
  WT (5)                                    30                   3.36 (0.28)                                                                         1.59                       NA                                            0.17 (0.08)                             NA
  WT (5)                                    60                   5.73 (0.19)                                                                         2.72                       NA                                            0.20 (0.06)                             NA
  *bubR1-KD* (5)                            0                    1.84 (0.12)                                                                         1                          0.97 (0.14)                                   NA                                      viable
  *bubR1-KD* (5)                            30                   2.67 (0.27)                                                                         1.45                       NA                                            0.58 (0.21)                             NA
  *bubR1-KD* (5)                            60                   4.59 (0.30)                                                                         2.50                       NA                                            1.41 (0.72)                             NA
  *bubR1-KEN* (5)                           0                    1.64 (0.10)                                                                         1                          0.67 (0.60)                                   NA                                      viable
  *bubR1-KEN* (5)                           30                   1.33 (0.23)                                                                         0.81                       NA                                            1.19 (0.47)                             NA
  *bubR1-KEN* (5)                           60                   1.25 (0.17)                                                                         0.77                       NA                                            3.99 (1.48)                             NA
  *bubR1-KEN asp* (3)                       0                    1.46 (0.10)                                                                         ND                         4.05 (0.73)                                   NA                                      lethal
  *asp* (4)                                 0                    7.40 (0.21)                                                                         ND                         1.03 (0.26)                                   NA                                      lethal
  *bubR1-KD cnn* (4)                        0                    2.92 (0.31)                                                                         ND                         1.07 (0.31)                                   NA                                      viable
  *bubR1-KEN cnn* (5)                       0                    2.06 (0.20)                                                                         ND                         15.22 (6.26)                                  NA                                      lethal
  *cnn* (3)                                 0                    2.65 (0.24)                                                                         ND                         0.83 (0.41)                                   NA                                      viable
  *bubR1-KD mad2^P^* (4)                    0                    1.93 (0.89)                                                                         1                          12.36 (4.22)                                  NA                                      lethal
  *bubR1-KD mad2^P^* (5)                    30                   1.33 (0.10)                                                                         0.69                       NA                                            2.68 (1.98)                             NA
  *bubR1-KD mad2^P^* (12)                   60                   1.20 (0.13)                                                                         0.62                       NA                                            4.79 (2.73)                             NA
  *bubR1-KEN mad2^P^* (5)                   0                    1.74 (0.18)                                                                         1                          0.53 (0.40)                                   NA                                      viable
  *bubR1-KEN mad2^P^* (5)                   30                   1.62 (0.12)                                                                         0.93                       NA                                            0.89 (0.17)                             NA
  *bubR1-KEN mad2^P^* (4)                   60                   1.57 (0.12)                                                                         0.91                       NA                                            1.58 (0.92)                             NA
  *mad2^P^* (5)                             0                    2.11 (0.26)                                                                         1                          0.77 (0.37)                                   NA                                      viable
  *mad2^P^* (5)                             30                   1.58 (0.12)                                                                         0.75                       NA                                            0.19 (0.18)                             NA
  *mad2^P^* (5)                             60                   1.63 (0.19)                                                                         0.77                       NA                                            0.19 (0.20)                             NA

NA, not applicable.

The number of brains is shown in parentheses.

Mitotic density is defined as the mean number of cells in mitosis per optic field.

SD is shown in parentheses.

This value was taken from [@bib4].

![**Structure of BubR1-KEN and BubR1-KD mutations and their effects on spindle function.** (A) Alignment of the N-terminal KEN box (left) and the kinase domain (right), indicating in red the residues altered in *bubR1-KEN* and the conserved lysine altered in *bubR1-KD*. (B--E) Thin K-fibers and unstable spindle length in *bubR1-KD* cells. (B) WT neuroblast in mitosis. Within a few minutes of NEB, it has established a stable spindle, developed robust K-fibers, and aligned chromosomes on the metaphase plate. Anaphase (ana) occurs at ∼7 min after NEB. See [Video 1](http://www.jcb.org/cgi/content/full/jcb.200905026/DC1). (C--E) Three different *bubR1-KD* neuroblasts displaying prolonged prometaphase. Chromosomes have difficulty congressing and remaining at the metaphase plate. The spindles appear diffuse, the K-fibers are poorly defined, and spindle length varies (compare the second and third frames of each series). Despite this aberrant behavior, each cell eventually enters anaphase, and the chromosomes segregate normally. See [Fig. S1](http://www.jcb.org/cgi/content/full/jcb.200905026/DC1) and [Videos 2 and 3](http://www.jcb.org/cgi/content/full/jcb.200905026/DC1). Videos in B--E are wide-field microscopy images of GFP-tubulin and mRFP1-Rod. (F) A *bubR1-KEN* mutant neuroblast with normal spindle morphology and dynamics. See [Video 5](http://www.jcb.org/cgi/content/full/jcb.200905026/DC1). Spinning disk confocal microscope images of GFP-tubulin and mRFP1--BubR1-KEN marking kinetochores (which become difficult to detect as anaphase approaches) are shown. Bar, 5 µm.](JCB_200905026_RGB_Fig1){#fig1}

Live imaging of *bubR1-KD* neuroblasts confirmed a tendency to prolong prometaphase and revealed significant problems in spindle function. WT spindles ([Fig. 1 B](#fig1){ref-type="fig"} and [Video 1](http://www.jcb.org/cgi/content/full/jcb.200905026/DC1)) rapidly captured and aligned chromosomes, within 2--5 min, spindle length was stable, and kinetochore fibers (K-fibers) increased in thickness as anaphase approached, reflecting maturation of the K-fiber bundle ([@bib20]). In contrast, in *bubR1-KD* cells, the time elapsing from NEB to anaphase was longer, and the distribution was much broader (10--31 min; mean 16.5 min) compared with WT (6--11 min; mean 9.1 min; P \< 0.0001; [Fig. 1, C--E](#fig1){ref-type="fig"}; and see [Fig. 3 A](#fig3){ref-type="fig"}). Chromosomes were slow to congress to the metaphase plate and sometimes had difficulty remaining aligned ([Fig. 1, D and E](#fig1){ref-type="fig"}; and [Videos 2 and 3](http://www.jcb.org/cgi/content/full/jcb.200905026/DC1); and see [Fig. 3 D](#fig3){ref-type="fig"}). Spindle K-fibers were often far thinner than in WT and sometimes remained so right up to anaphase onset. Finally, the *bubR1-KD* spindle length was unstable during prometaphase and metaphase ([Fig. 1, C--E](#fig1){ref-type="fig"}; [Fig. S1](http://www.jcb.org/cgi/content/full/jcb.200905026/DC1); and Videos 2 and 3), often shrinking soon after NEB. Some spindles reattained full length before anaphase onset. Of 19 spindles examined, 11 (55%) displayed this length instability versus 1/20 (5%) of WT. Despite these defects, chromosomes segregated accurately at anaphase ([Fig. S2, A and B](http://www.jcb.org/cgi/content/full/jcb.200905026/DC1)), a well-formed central spindle developed, and cytokinesis ensued without obvious difficulty (Videos 2 and 3).

BubR1 is needed for correct K--MT attachments ([@bib16]), but the specific role of its kinase activity to this function is unclear. [@bib35] and [@bib11] found that BubR1-KD was unable to promote efficient chromosome capture and congression. [@bib6] and [@bib21] reported only minor defects of chromosome attachment. The different results may reflect different efficiencies of depleting the endogenous WT BubR1. Our genetic system (expressing mutant transgenes in the genetically null *bubR1* background) avoids this potential pitfall.

The thin K-fibers, chromosome congression delays, and unstable metaphase alignments seen in our *bubR1-KD* cells support an important role for the kinase in promoting K--MT attachments and are similar to the phenotypes described in mammalian cells after siRNA treatment ([@bib16]). The unstable spindle length has not been previously described in *bubR1-KD* mutants in other model systems, but this too may be a consequence of defective K--MT attachments or, more specifically, alterations in the activities of kinetochore-associated factors influencing MT stability or dynamics. Depletion of proteins such as CLASP or EB1, which bind to and stabilize MT+ ends, leads to shortened spindles and congression problems ([@bib19]; [@bib8]). Such proteins or their regulators are thus potential candidates for BubR1 phosphorylation.

Robust SAC in *bubR1-KD* mutants
--------------------------------

Because *bubR1-KD* cells with abnormal spindles delayed anaphase onset and had only low rates of aneuploidy, they appeared to have a functional SAC. To test whether this delay was indeed SAC dependent, we made double mutants of *bubR1-KD* and *mad2^P^*, a null mutation of *mad2* which eliminates the SAC but is viable and generates little or no aneuploidy on its own ([@bib4]). These *bubR1-KD mad2^P^* cells were no longer delayed in prometaphase like *bubR1-KD* (mean 16.5 min) but instead showed the rapid mitotic transit time (mean 7.8 min) and early onset of cyclin B degradation (OCBD) typical of *mad2^P^* ([Video 4](http://www.jcb.org/cgi/content/full/jcb.200905026/DC1); and see [Fig. 3, A and E](#fig3){ref-type="fig"}; and [Fig. 4, B and C](#fig4){ref-type="fig"}). Moreover, double mutant individuals were uniformly larval/pupal lethals, brains had a lower mitotic density, neuroblasts were much more often aneuploid (12%; [Table I](#tbl1){ref-type="table"}), and abnormal anaphases were more frequent (Fig. S2, C and D) than in either mutant alone. These results confirmed that the SAC was acting in *bubR1-KD* to protect the cells from premature anaphase. In a second test, *bubR1-KD* brains were treated with colchicine to depolymerize MTs. After 1 h, the mitotic density rose 2.5-fold, similar to WT (2.7-fold; [Fig. 2, A and B](#fig2){ref-type="fig"}; and [Table I](#tbl1){ref-type="table"}). Finally, we assayed the ability of *bubR1-KD* to provide the SAC activity needed for *cnn* (*centrosomin*) mutants to successfully complete mitosis. *cnn* cells have no functional centrosomes, and spindle assembly takes longer than WT. *cnn* cells are delayed in prometaphase by the SAC: removing Mad2 (in *mad2 cnn* double mutants) shortens prometaphase, raises aneuploidy rates from 1% in *cnn* alone to 18%, and kills the normally viable *cnn* flies ([@bib4]). In contrast, *bubR1-KD cnn* double mutants maintained the low aneuploid rates (around 1%) of *bubR1-KD* or *cnn* alone ([Table I](#tbl1){ref-type="table"}), and they survived to adulthood. By all of the aforementioned criteria, the *bubR1-KD* SAC is functional.

![***bubR1-KD* mutants are checkpoint competent, but *bubR1-KEN* mutants are checkpoint defective.** (A--C) Representative fields of cells from larval brains incubated in colchicine for 60 min. WT (A) or *bubR1-KD* mutant (B) cells accumulate in prometaphase, whereas *bubR1-KEN* mutants do not (C). However, PSCS is common in both mutants (boxed areas and insets in B and C). (D and E) The very high mitotic density caused by mutations in *asp* (D) is suppressed in *bubR1-KEN asp* double mutants (E). The number of anaphases (very rare in *asp*) also rises (oval in E). See [Table I](#tbl1){ref-type="table"}. Yellow circles and ovals mark mitotic cells in the fields. Orcein-stained preparations are shown. Bar, 10 µm.](JCB_200905026_RGB_Fig2){#fig2}

However, the SAC in *bubR1-KD* may not be entirely normal. Premature sister chromatid separation (PSCS) rose sevenfold after 60 min in colchicine to 1.4% (vs. 0.2% in WT). PSCS is usually considered a sign of mitotic exit and therefore of SAC failure. These results might indicate some weakness in long-term maintenance of metaphase.

There is much conflicting data on the role of the BubR1 kinase in the SAC, in part because different assays for SAC activity are used. BubR1 protein bearing mutations (or deletions) of the kinase domain can inhibit APC/C ([@bib5]; [@bib34]), yet some studies in vivo or in mitotic extracts concluded that the kinase activity is critical ([@bib22]; [@bib14]), whereas others found it is important only for prolonged nocodazole-induced mitotic arrest ([@bib11]; [@bib21]).

Our data are consistent with this latter conclusion. However it is not clear that the inability to maintain prolonged mitotic arrest should be regarded as a weak SAC, which presumably would be less sensitive to unattached kinetochores than a strong SAC. It would then arrest cells with many unattached kinetochores (as after nocodazole treatment) but not cells with just a few. Studies measuring the duration of a SAC-mediated arrest in nocodazole may be measuring some other property unrelated to the SAC (for review see [@bib27]).

The kinetochore protein CenpE reportedly binds to and regulates BubR1 kinase activity ([@bib22]); thus, one might expect depletion of Cmet, the fly homologue of CenpE, to have a phenotype similar to *bubR1-KD*. Indeed, *cmet* mutant cells are delayed in prometaphase, but they exit mitosis in colchicine ([@bib33]). However, unlike *bubR1-KD*, *cmet* mutants are highly aneuploid and lethal. Moreover, the spindle defects after *cmet* and *bubR1* RNAi treatment differ ([@bib18]). This suggests that Cmet may affect the SAC and the kinetochore independently of BubR1. Cmet itself is still recruited to *bubR1-KD* kinetochores (unpublished data).

To conclude, the kinase activity of BubR1 is substantially more important for spindle function than for the SAC. In *bubR1-KD*, spindles inefficiently make proper K--MT connections, whereas the SAC is relatively unaffected: it can arrest cells for up to1 h in colchicine, and when spindle function is compromised (as in *bubR1-KD* and *cnn* cells), it can delay anaphase to assure accurate chromosome segregation and low aneuploidy rates. Because in *Drosophila* the prometaphase--metaphase period typically lasts 9 min and an entire neuroblast cell cycle may last only 1 h ([@bib32]), the value of a SAC capable of longer-term arrest is likely to be negligible.

No SAC but normal mitosis in *bubR1-KEN* and *bubR1-KEN mad2* double mutant flies
---------------------------------------------------------------------------------

To make a checkpoint-dead BubR1, we mutated the N-terminal KEN box (K7, E8, and N9) to AAN ([Fig. 1 A](#fig1){ref-type="fig"}). Flies with this mutation, called in this study *bubR1-KEN*, were viable and fertile, and aneuploidy in the larval neuroblasts was very low (0.7%; [Table I](#tbl1){ref-type="table"}), similar to that reported for the *mad2^P^*-null mutation ([@bib4]).

Colchicine failed to arrest *bubR1-KEN* cells in mitosis ([Fig. 2 C](#fig2){ref-type="fig"} and [Table I](#tbl1){ref-type="table"}), and PSCS was frequent, 20-fold higher than in WT. Likewise, the high mitotic density caused by the *asp* (*abnormal spindle*) mutation was reduced fivefold in *bubR1-KEN asp* double mutants ([Fig. 2, D and E](#fig2){ref-type="fig"}; and [Table I](#tbl1){ref-type="table"}), similar to the reduction seen when *asp* is combined with other SAC mutations ([@bib1]; [@bib4]). Finally, and in contrast to *bubR1-KD*, double mutants of *bubR1-KEN* and *cnn* were pupal lethal with aneuploidy averaging 15% ([Table I](#tbl1){ref-type="table"}). *bubR1-KEN* neuroblasts showed no obvious defects in spindle structure or function ([Fig. 1 F](#fig1){ref-type="fig"} and [Video 5](http://www.jcb.org/cgi/content/full/jcb.200905026/DC1)). Stable spindles rapidly captured chromosomes and formed robust K-fibers, often within 3 min of NEB, as in WT. Anaphase figures presented normal symmetrical chromatids (Fig. S2, E and F). By all of these criteria, the mitotic phenotype of *bubR1-KEN* mutants is similar to *mad2^P^* ([@bib4]): viable, little aneuploidy, and normal spindle function but SAC defective.

Thus, the KEN box is critical to the SAC function of fly BubR1, as it is for yeast Mad3 ([@bib28]). [@bib21] recently reported that expressing the N-terminal third of BubR1 (lacking the kinase domain and a second Cdc20-binding domain) restores substantial but not total SAC activity to *bubR1*-null mouse fibroblasts, and removing the N-terminal KEN box eliminates this activity and also perturbs K--MT attachments. Our BubR1-KEN mutant is a full-length protein, including the kinase domain, and its failure to provide any detectable SAC activity confirms and extends those observations (and suggests again that the kinase on its own can do little or nothing for the SAC). However, we see no effect of the KEN domain on K--MT attachments.

Much biochemical and genetic data argue that the SAC depends on both Mad2 and BubR1 in a single pathway ([@bib24]), but there are studies to the contrary. For example, [@bib26] found that *Drosophila* S2 cells could sustain a Mad2-independent (but BubR1 dependent) mitotic arrest under certain conditions. [@bib30] reported that Mad2 and BubR1 detect different kinds of K--MT problems. Moreover, the BubR1--Cdc20 complex on its own is a good in vitro inhibitor of the APC/C ([@bib31]; [@bib5]; [@bib7]). Thus, it was just conceivable that the normal mitosis of *mad2^P^* flies described in [@bib4] depended on a residual SAC activity provided by BubR1.

To test whether cells lacking both putative branches of the SAC could still divide accurately, we made *bubR1-KEN mad2^P^* double mutants. These flies were once again viable and fertile, aneuploidy was no higher than in *bubR1-KEN* or *mad2^P^* mutants alone ([Table I](#tbl1){ref-type="table"}), and anaphase figures appeared normal (Fig. S2, G and H). This confirms that mitosis in *Drosophila* is normally highly accurate even in the absence of a functional SAC ([@bib4]).

Separating the timer from the SAC
---------------------------------

The mitotic timer regulates the interval elapsing between NEB and anaphase onset independently of any SAC-imposed delay caused by unattached kinetochores ([@bib23]). Depletion of BubR1 or Mad2 (but not other SAC proteins) shortens this interval, and simultaneous depletion of both proteins accelerates the pace even further ([@bib23]). This suggests that BubR1 and Mad2 have a timer function, possibly distinct from their checkpoint function, but because only these two SAC proteins bind Cdc20, the timer complex presumably also inhibits the APC/C and may be similar or identical to the SAC complex ([@bib24]; [@bib25]; [@bib15]).

Surprisingly, mitotic timing was normal in *bubR1-KEN* cells ([Fig. 3 B](#fig3){ref-type="fig"}). Whereas *mad2^P^* neuroblasts averaged 7.8 min from NEB to anaphase (vs. 9.1 min for WT; P \< 0.001), *bubR1-KEN* timing was no different from WT (9.2 min; [Fig. 3, B, C, and F](#fig3){ref-type="fig"}; and [Video 6](http://www.jcb.org/cgi/content/full/jcb.200905026/DC1)). Thus, even though the SAC was entirely nonfunctional, the timer was intact. However, the timer made by BubR1-KEN required Mad2: in *bubR1-KEN mad2^P^* cells, timing averaged 5.4 min, 40% faster than *bubR1-KEN* or WT and 30% faster than *mad2^P^* cells (P \< 0.005; [Fig. 3, B, F, and G](#fig3){ref-type="fig"}; and [Videos 6 and 7](http://www.jcb.org/cgi/content/full/jcb.200905026/DC1)).

![**Mitotic timing in *bubR1-KD*, *bubR1-KEN*, and double mutants with *mad2*.** (A) Comparative mitotic transit times for WT, *bubR1-KD*, *mad2*, and *bubR1-KD mad2* double mutants. *bubR1-KD* cells are profoundly delayed, averaging 16.5 min versus 9.1 min in WT. In *mad2* cells, anaphase is, on average, 2 min earlier than in WT ([@bib4]). *bubR1-KD mad2* double mutant cells show the same timing as *mad2* alone, revealing that the prometaphase delay in *bubR1-KD* is SAC dependent. (B) Comparative mitotic timing of *bubR1-KEN* and *bubR1-KEN mad2* double mutant cells. *bubR1-KEN* cells show no change in timing relative to WT. In contrast, *bubR1-KEN mad2* double mutant cells enter anaphase even earlier than *mad2* mutant cells alone (5.4 min vs. 7.8 min; P \< 0.005). (C--G) Frames from typical videos used to determine mitotic timing (NEB to anaphase \[ana\]). WT (C), *bubR1-KD* (D), *bubR1-KD mad2* double mutants (E), *bubR1-KEN* (F), and *bubR1-KEN mad2* double mutants (G) are shown. All cells but the one in E are marked with GFP-Rod. The cell in E is marked with GFP--BubR1-KD. See [Videos 4, 6, and 7](http://www.jcb.org/cgi/content/full/jcb.200905026/DC1). Bar, 5 µm.](JCB_200905026_RGB_Fig3){#fig3}

This acceleration was accompanied by a correspondingly earlier OCBD, starting on average just 3 min after NEB (vs. 4.7 min for *mad2*; P \< 0.02; [Fig. 4, B, E, and F](#fig4){ref-type="fig"}), whereas in *bubR1-KEN* cells, OCBD was similar to WT (6 min from NEB; [Fig. 4, A, D, and F](#fig4){ref-type="fig"}; and [Videos 8--10](http://www.jcb.org/cgi/content/full/jcb.200905026/DC1)). In contrast, the gap from OCBD to anaphase was relatively constant for all genotypes ([Fig. 4](#fig4){ref-type="fig"}). That OCBD is affected in the timer-defective mutants suggests that the timer is indeed regulating the activation of the APC/C.

![**Cyclin B degradation profiles reflect the mitotic timing in *bubR1-KEN* and double mutant *bubR1-KEN mad2* neuroblasts.** Typical degradation profiles of GFP--cyclin B disappearance in single neuroblasts. (A--E) WT (A), *mad2* (B), *bubR1-KD mad2* (C), *bubR1-KEN* (D), and *bubR1-KEN mad2* (E). The OCBD is unaffected by *bubR1-KEN*, beginning ∼6 min after NEB and 2--3 min before anaphase, as in WT. (F) Mean time of OCBD versus NEB (left) and anaphase (ANA) onset (right). OCBD begins 1.6 min earlier in *mad2* or *bubR1-KD mad2* mutant cells but 3 min earlier in *bubR1-KEN mad2* mutant cells. Error bars indicate SD. See [Videos 8--10](http://www.jcb.org/cgi/content/full/jcb.200905026/DC1) and [@bib4]. Bar, 5 µm.](JCB_200905026R_RGB_Fig4){#fig4}

Thus, the dichotomy between timer activity and checkpoint activity exists within BubR1 and can be separated. The KEN domain of BubR1 is specifically required to generate SAC inhibitor but is dispensable for the timer. This raises the possibility that the two complexes may be different biochemical entities or are generated by different pathways.

Alternatively, the difference between timer and checkpoint activity may be simply quantitative. The SAC may need a high inhibitor level, the timer only a low one. If BubR1-KEN still makes the inhibitor, but only inefficiently, it might (with the help of Mad2) still supply the low levels needed for normal timing, whereas the higher levels required for the SAC would need both Mad2 and intact BubR1. In contrast, intact BubR1 alone (in a *mad2* mutant) would not make enough inhibitor even for the timer, and BubR1-KEN alone (in the double mutant *bubR1-KEN mad2*) would make even less, so timing would be faster still.

We have shown that the three mitotic functions of *Drosophila* BubR1 protein can be uncoupled, as assayed in vivo. The kinase domain mutation perturbs spindle function but has little, if any, effect on the SAC under normal conditions. The N-terminal KEN box mutation eliminates the SAC, but has no effect on the mitotic timer nor on spindle function. This reinforces the conclusion of [@bib4] that the SAC is a checkpoint as defined by [@bib10]: it is not an intrinsic component of the mitotic machinery but just a surveillance mechanism. The checkpoint phenotype previously ascribed to BubR1 in RNAi knockdown or null mutations ([@bib2]; [@bib14]) is a composite phenotype, the consequences of perturbing spindle function, eliminating the SAC, and accelerating the clock. Being able to separate them should facilitate future study of BubR1's roles at the kinetochore.

Materials and methods
=====================

Flies
-----

The *bubR1^1^* mutation (gift from M. Goldberg, Cornell University, Ithaca, New York) of *bubR1* (CG7838) is genetic null ([@bib2]; [@bib17]). Flies expressing GFP-Rod, RFP-Rod, and the mutations *mad2^P^*, *cnn* allele *cnn^hk21^*, and *asp* allele *asp^E3^* were described previously ([@bib3], [@bib4]). GFP-tubulin and GFP--cyclin B flies were a gift from J. Raff (Cancer Research UK Gurdon Institute, Cambridge, England, UK).

Construction of *bubR1 K1204A* (*bubR1-KD*) and *bubR1-KEN*
-----------------------------------------------------------

For BubR1-KD, mutagenizing primers were used to substitute an alanine for the nearly invariant lysine 1,204 (kinase subdomain II; [Fig. 1 A](#fig1){ref-type="fig"}). Mutations at the homologous position in vertebrate BubR1 (K795 in human) had already been used in several other studies ([@bib31]; [@bib5]; [@bib22]; [@bib14]; [@bib9]; [@bib36]), some of which directly confirmed its loss of kinase activity. The mutation was put in both a WT BubR1--expressing *P* element transgene and a GFP-tagged version of BubR1 (controlled by the natural *bubR1* promoter), which fully complements *bubR1^1^* and recapitulates endogenous BubR1 behavior during mitosis ([@bib3]). For BubR1-KEN, residues K7, E8, and N9 (corresponding to the Mad3 N-terminal KEN box shown to be critical to the SAC in yeast; [@bib13]; [@bib28]) were changed to A7, A8, and N9 (AAN) by using a mutagenizing primer in a monomeric RFP1 (mRFP1)--BubR1 construct ([@bib3]). The constructs were introduced into the germ line of *w^1118^* flies by the services of BestGene, Inc. The transgenes (*P\[bubR1^KD^\]*, *P\[GFP-bubR1^KD^\]*, or *P\[RFP-bubR1^KEN^\]*) were then crossed into the *bubR1^1^* genetic background. These flies of genotype *bubR1^1^*; *P\[bubR1^KD^\]* and *bubR1^1^*; *P\[bubR1^KEN^\]* are called *bubR1-KD* and *bubR1-KEN* flies in this paper. Western blots of transgenic BubR1 variants ([Fig. S3](http://www.jcb.org/cgi/content/full/jcb.200905026/DC1)) were performed as previously described ([@bib4]) using the anti-BubR1 previously described (gift from C. Sunkel; [@bib17]) and anti--α tubulin (Sigma-Aldrich). In brief, protein extracts from 50 brains of WT, BubR1-KD, BubR1-KEN (each expressed in the *bubR1^1^* mutant background), and *bubR1^1^* homozygous third instar larvae were loaded onto 8% SDS--acrylamide gels. Proteins were transferred to nitrocellulose membrane (Protran BA 85; Schleicher-Schuell) using an electrophoretic blotting device (Mini protean 3; Bio-Rad Laboratories). Membranes were blocked for 1 h in TBST (TBS and 0.1% Tween) with 5% dry milk and incubated for 1.5 h with anti-BubR1 diluted at 1:4,000 in TBST plus 1% milk. After washing in TBST, the blot was incubated for 1 h at room temperature with secondary antibody of goat anti--rabbit IgG conjugated with horseradish peroxidase (Bio-Rad Laboratories) diluted at 1:60,000. Immunodetection was performed with the SuperSignal kit (Thermo Fisher Scientific). Membranes were stripped and incubated with mouse anti--α-tubulin (Sigma-Aldrich) diluted at 1:1,000 to verify equal loading of proteins.

Cytology
--------

For simple cytology of mitotic cells, third instar larval brains were fixed and stained in aceto-orcein as previously described ([@bib4]). Larvae were washed in water, and their brains were dissected in a drop of isotonic saline. The tissue was fixed by transferring it to a drop of 45% acetic acid for 30 s, followed by 60% acetic acid for an additional 15 s. Finally, the brains were stained with a drop of aceto-orcein (2% solution in 60% acetic acid) on a clean siliconized coverslip for 1 min. The coverslip was then picked up with a clean microscope slide, and the tissue was squashed with pressure applied from a thumb over the coverslip area. To determine the mitotic density (mean number of mitotic cells per microscopic field) in response to colchicine-induced depolymerization of MTs ([Table I](#tbl1){ref-type="table"}), brains were preincubated in 10^−4^ M colchicine in 0.7% NaCl for 0, 30, or 60 min and transferred to 0.5% Na citrate hypotonic solution for exactly 4 min before staining. The absolute frequency of PSCS was lower using these conditions for both WT and SAC-defective cells, but the relative increase was the same as reported previously using longer hypotonic incubations ([@bib2]; [@bib1]).

To determine aneuploidy, brains were preincubated in 10^−4^ M colchicine in 0.7% NaCl for 7 min, transferred to 0.5% Na citrate hypotonic solution for 4 min, and then fixed and stained. (This brief colchicine treatment aids in obtaining readable karyotypes; it is not used to test the SAC function.) Cells were observed with a microscope (Microphot; Nikon) and a 63× NA 1.4 phase contrast objective (Carl Zeiss, Inc.). A cell was considered aneuploid if it clearly had at least one extra chromosome.

In vivo imaging
---------------

Third instar larval brains were dissected in Shields and Sang M3 insect medium (Sigma-Aldrich) with 10% FBS and penicillin-streptomycin. Three to four larval brains were immediately transferred into 15 µl of M3 medium supplemented with 10% FBS, penicillin-streptomycin, 10 µg/ml insulin, and 5 µg/ml of fly extract and then placed on a standard membrane in a stainless steel slide, as described previously ([@bib29]).

Brains were imaged at room temperature with a spinning disk confocal head (Ultraview; PerkinElmer) mounted on an inverted microscope (DMI6000; Leica) with a 100× NA 1.4 lens and a camera (QuantEM 512SC; Photometrics), all piloted by MetaMorph 7 (MDS Analytical Technologies). At 20-s intervals, a z series of images consisting of seven 1-µm steps was acquired with 1× binning. Confocal video frames are maximum intensity projections. Time-lapse image series were converted into videos with ImageJ software (National Institutes of Health), and still images were processed using Photoshop (Adobe). For mitotic timing, NEB was defined as when the RFP- or GFP-Rod signal began to be visible on kinetochores. Anaphase onset was defined as the moment sister kinetochores (marked with Rod) began to separate. In some films, we followed RFP-BubR1, in which case NEB was defined as the moment the RFP signal on kinetochores began to rapidly intensify (because some signal is present even in prophase; [@bib3]). To be consistent, only neuroblasts were scored (recognizable by their size and their asymmetric division) and not other cells. For GFP--cyclin B dynamics, neuroblasts expressing one copy of GFP--cyclin B and RFP-Rod were filmed as above. GFP fluorescence in each z section was quantified for the whole cell and for a central region containing the kinetochores and most of the spindle. This gave a more robust measurement of the OCBD because spindle-associated cyclin B is the first to be degraded during metaphase ([@bib4]). The signal was adjusted for background and for bleaching relative to the signal of a neighboring nonmitotic cell (assumed to be constant). In the graphs for [Fig. 4](#fig4){ref-type="fig"}, the signal levels for the whole cell are displayed as normalized signal relative to the maximal intensity measured for the cell.

For the observations of GFP-tubulin in living neuroblasts, brains were gently squashed in a drop of 0.7% saline between a coverslip and a slide. Excess liquid was removed with a paper tissue while observing the flattening of the brain under a dissecting microscope. Once the desired flatness was obtained (the brain typically flattens to a disk ∼2 mm in diameter), the preparation was sealed by drawing a drop of halocarbon oil around the periphery of the coverslip ([@bib3]). Fluorescent time-lapse videos were acquired with an inverted microscope (IX-70; Olympus), xenon lamp, and camera (OrcaER; Hamamatsu Photonics), piloted by the Cell-R hardware and software system (Olympus). Acquisition times per frame were 100 ms for GFP and 300 ms for mRFP1. Images were collected at 10-, 15-, or 20-s intervals with a 60× NA 1.4 objective and 1× binning.

Online supplemental material
----------------------------

Fig. S1 shows the evolution of neuroblast spindle length as a function of time from NEB. Fig. S2 shows representative anaphase figures from WT and mutant neuroblasts. Fig. S3 shows Western blots comparing expression levels of endogenous BubR1 (WT) with homozygous transgenic lines expressing BubR1-KD and BubR1-KEN in the *bubR1^1^* mutant background. Videos 1--3 and 5 show spindle assembly (GFP-tubulin) and mitosis in WT (Video 1), in two examples of *bubR1-KD* mutant (Videos 2 and 3), and in an example of *bubR1-KEN* mutant (Video 5) neuroblasts, corresponding to [Fig. 1 (B and D--F)](#fig1){ref-type="fig"}. Videos 4, 6, and 7 show examples of mitotic timing in *bubR1-KD mad2^P^*, *bubR1-KEN*, and *bubR1-KEN mad2^P^* double mutant neuroblasts, respectively, corresponding to [Fig. 3 (E--G)](#fig3){ref-type="fig"}. Videos 8--10 show GFP--cyclin B degradation during mitosis in WT, *bubR1-KEN*, and *bubR1-KEN mad2^P^* neuroblasts, respectively, corresponding to [Fig. 4 (A, D, and E)](#fig4){ref-type="fig"}. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.200905026/DC1>.
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